Basilea Pharmaceutica AG
BPMUF
$54.00
$1.172.22%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.51% | 186.65% | -3.31% | 198.19% | 0.25% |
| Total Depreciation and Amortization | -1.51% | 260.22% | -3.30% | -70.83% | -0.26% |
| Total Amortization of Deferred Charges | -1.53% | -4.35% | -3.31% | -52.11% | -0.25% |
| Total Other Non-Cash Items | 1.51% | 64.24% | 3.31% | -1,060.34% | -0.25% |
| Change in Net Operating Assets | -1.44% | -97.76% | -3.31% | -32.02% | -0.25% |
| Cash from Operations | -1.51% | 229.30% | -3.31% | 338.19% | 0.25% |
| Capital Expenditure | 1.50% | -178.27% | 3.33% | 5.22% | 0.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -100.00% | -3.31% | -- | -- |
| Other Investing Activities | 1.79% | 42.66% | 3.30% | 63.23% | 0.36% |
| Cash from Investing | 1.51% | -609.56% | -3.35% | 140.99% | 0.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 0.00% | 61.84% | 0.00% |
| Issuance of Common Stock | 0.00% | -93.64% | 0.00% | 120.92% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -214.19% | 0.00% | 138.54% | 0.00% |
| Cash from Financing | 1.57% | 99.83% | 3.31% | 66.91% | 0.25% |
| Foreign Exchange rate Adjustments | 1.47% | -156.55% | -3.21% | 179.36% | 0.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 0.00% |
| Net Change in Cash | -1.51% | 1,018.78% | -3.31% | 110.72% | 0.25% |
